201 related articles for article (PubMed ID: 30826536)
1. Biodegradation of graphene-based nanomaterials in blood plasma affects their biocompatibility, drug delivery, targeted organs and antitumor ability.
Li D; Hu X; Zhang S
Biomaterials; 2019 May; 202():12-25. PubMed ID: 30826536
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in graphene-family nanomaterials for effective drug delivery and phototherapy.
Jiang C; Zhao H; Xiao H; Wang Y; Liu L; Chen H; Shen C; Zhu H; Liu Q
Expert Opin Drug Deliv; 2021 Jan; 18(1):119-138. PubMed ID: 32729733
[TBL] [Abstract][Full Text] [Related]
3. Graphene in the aquatic environment: adsorption, dispersion, toxicity and transformation.
Zhao J; Wang Z; White JC; Xing B
Environ Sci Technol; 2014 Sep; 48(17):9995-10009. PubMed ID: 25122195
[TBL] [Abstract][Full Text] [Related]
4. Biological interactions of graphene-family nanomaterials: an interdisciplinary review.
Sanchez VC; Jachak A; Hurt RH; Kane AB
Chem Res Toxicol; 2012 Jan; 25(1):15-34. PubMed ID: 21954945
[TBL] [Abstract][Full Text] [Related]
5. Principles and Biomedical Application of Graphene Family Nanomaterials.
Raja IS; Lone S; Han DW; Hong SW
Adv Exp Med Biol; 2022; 1351():3-22. PubMed ID: 35175609
[TBL] [Abstract][Full Text] [Related]
6. Graphene Family of Nanomaterials: Reviewing Advanced Applications in Drug delivery and Medicine.
Joshi K; Mazumder B; Chattopadhyay P; Bora NS; Goyary D; Karmakar S
Curr Drug Deliv; 2019; 16(3):195-214. PubMed ID: 30381073
[TBL] [Abstract][Full Text] [Related]
7. Differential modulation of endothelial cytoplasmic protrusions after exposure to graphene-family nanomaterials.
Ardoña HAM; Zimmerman JF; Shani K; Kim SH; Eweje F; Bitounis D; Parviz D; Casalino E; Strano M; Demokritou P; Parker KK
NanoImpact; 2022 Apr; 26():100401. PubMed ID: 35560286
[TBL] [Abstract][Full Text] [Related]
8. Graphene Family Nanomaterials in Ocular Applications: Physicochemical Properties and Toxicity.
Borandeh S; Alimardani V; Abolmaali SS; Seppälä J
Chem Res Toxicol; 2021 Jun; 34(6):1386-1402. PubMed ID: 34041903
[TBL] [Abstract][Full Text] [Related]
9. Differential genotoxic and epigenotoxic effects of graphene family nanomaterials (GFNs) in human bronchial epithelial cells.
Chatterjee N; Yang J; Choi J
Mutat Res Genet Toxicol Environ Mutagen; 2016 Mar; 798-799():1-10. PubMed ID: 26994488
[TBL] [Abstract][Full Text] [Related]
10. Graphene-based nanomaterials for drug delivery and tissue engineering.
Goenka S; Sant V; Sant S
J Control Release; 2014 Jan; 173():75-88. PubMed ID: 24161530
[TBL] [Abstract][Full Text] [Related]
11. Advances on graphene-based nanomaterials for biomedical applications.
Qu Y; He F; Yu C; Liang X; Liang D; Ma L; Zhang Q; Lv J; Wu J
Mater Sci Eng C Mater Biol Appl; 2018 Sep; 90():764-780. PubMed ID: 29853147
[TBL] [Abstract][Full Text] [Related]
12. Detection and Quantification of Graphene-Family Nanomaterials in the Environment.
Goodwin DG; Adeleye AS; Sung L; Ho KT; Burgess RM; Petersen EJ
Environ Sci Technol; 2018 Apr; 52(8):4491-4513. PubMed ID: 29505723
[TBL] [Abstract][Full Text] [Related]
13. Recent Developments of Phototherapy Based on Graphene Family Nanomaterials.
Zhang B; Wang Y; Liu J; Zhai G
Curr Med Chem; 2017; 24(3):268-291. PubMed ID: 27774874
[TBL] [Abstract][Full Text] [Related]
14. Functionalization of graphene family nanomaterials for application in cancer therapy.
de Melo-Diogo D; Lima-Sousa R; Alves CG; Costa EC; Louro RO; Correia IJ
Colloids Surf B Biointerfaces; 2018 Nov; 171():260-275. PubMed ID: 30041150
[TBL] [Abstract][Full Text] [Related]
15. Aqueous aggregation and stability of graphene nanoplatelets, graphene oxide, and reduced graphene oxide in simulated natural environmental conditions: complex roles of surface and solution chemistry.
Ye N; Wang Z; Wang S; Fang H; Wang D
Environ Sci Pollut Res Int; 2018 Apr; 25(11):10956-10965. PubMed ID: 29399742
[TBL] [Abstract][Full Text] [Related]
16. EPS-corona formation on graphene family nanomaterials (GO, rGO and graphene) and its role in mitigating their toxic effects in the marine alga Chlorella sp.
Debroy A; Roy N; Giri S; Pulimi M; Chandrasekaran N; Peijnenburg WJGM; Mukherjee A
Environ Pollut; 2024 Jan; 341():123015. PubMed ID: 38008250
[TBL] [Abstract][Full Text] [Related]
17. Toxicity of graphene-family nanoparticles: a general review of the origins and mechanisms.
Ou L; Song B; Liang H; Liu J; Feng X; Deng B; Sun T; Shao L
Part Fibre Toxicol; 2016 Oct; 13(1):57. PubMed ID: 27799056
[TBL] [Abstract][Full Text] [Related]
18. Graphene-based nanomaterials for nanobiotechnology and biomedical applications.
Krishna KV; Ménard-Moyon C; Verma S; Bianco A
Nanomedicine (Lond); 2013 Oct; 8(10):1669-88. PubMed ID: 24074389
[TBL] [Abstract][Full Text] [Related]
19. Toxicology data of graphene-family nanomaterials: an update.
Xiaoli F; Qiyue C; Weihong G; Yaqing Z; Chen H; Junrong W; Longquan S
Arch Toxicol; 2020 Jun; 94(6):1915-1939. PubMed ID: 32240330
[TBL] [Abstract][Full Text] [Related]
20. Potential Biomedical Limitations of Graphene Nanomaterials.
Ban G; Hou Y; Shen Z; Jia J; Chai L; Ma C
Int J Nanomedicine; 2023; 18():1695-1708. PubMed ID: 37020689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
